Patients presenting with high risk stage II disease and stage III disease are candidates for adjuvant chemotherapy with an oxaliplatin based regimen in combination with 5 FU plus leucovorin FOLFOX or with oral capecitabine XELOX and are generally treated for 6 months following surgical resection

مهمان عزیز شما حق دیدن لینک ها را ندارید برای استفاده از امکانات کامل انجمن عضو شوید

عضویت